參考文獻/References:
[1] MA S,QIN J,HAO Y,et al.Structural and functional changes of gut microbiota in ovariectomized rats and their correlations with altered bone mass[J].Aging(Albany NY),2020,12(11):10736-10753.
[2] CORNELISSEN D,DE KUNDER S,SI L,et al.Interventions to improve adherence to anti-osteoporosis medications:an updated systematic review[J].Osteoporos Int,2020,31(9):1645-1669.
[3] FAN Z,LI X,ZHANG X,et al.Comparison of OSTA,FRAX and BMI for predicting postmenopausal osteoporosis in a Han population in Beijing:a cross sectional study[J].Clin Interv Aging,2020,15:1171-1180.
[4] AIBAR-ALMAZÁN A,VOLTES-MARTÍNEZ A,CASTELLOTE-CABALLERO Y,et.al.Current status of the diagnosis and management of osteoporosis[J].Int J Mol Sci,2022,23(16):9465.
[5] KITAURA H,KIMURA K,ISHIDA M,et al.Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo[J].Clin Dev Immunol,2013:181849.
[6] OHLSSON C,NIGRO G,BONECA I G,et al.Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling[J].Cell Immunol,2017,317:55-58.
[7] ZHANG Y W,CAO M M,LI Y J,et al.A narrative review of the moderating effects and repercussion of exercise intervention on osteoporosis:ingenious involvement of gut microbiota and its metabolites[J].J Transl Med,2022,20(1):490.
[8] SONG Z,LI S,LI R.An investigation into the correlation of intestinal flora with obesity and gestational diabetes mellitus[J].Comput Math Methods Med,2022:5677073.
[9] WANG J,DONG P,ZHENG S,et al.Advances in gut microbiome in metabonomics perspective:based on bibliometrics methods and visualization analysis[J].Front Cell Infect Microbiol,2023,13:1196967.
[10] CAMPBELL C,KANDALGAONKAR M R,GOLONKA R M,et al.Crosstalk between gut microbiota and host immunity:impact on inflammation and immunotherapy[J].Biomedicines,2023,11(2):294.
[11] PEDROZA MATUTE S,IYAVOO S.Exploring the gut microbiota:lifestyle choices,disease associations,and personal genomics[J].Front Nutr,2023,10:1225120.
[12] SPENCER S P,FRAGIADAKIS G K,SONNENBURG J L.Pursuing human-relevant gut microbiota-immune interactions[J].Immunity,2019,51(2):225-239.
[13] SASSO J M,AMMAR R M,TENCHOV R,et al.Gut microbiome-brain alliance:a landscape view into mental and gastrointestinal health and disorders[J].ACS Chem Neurosci,2023,14(10):1717-1763.
[14] CAMPBELL C,KANDALGAONKAR M R,GOLONKA R M,et al.Crosstalk between gut microbiota and host immunity:impact on inflammation and immunotherapy[J].Biomedicines,2023,11(2):294.
[15] ZHOU B,YUAN Y,ZHANG S,et al.Intestinal flora and disease mutually shape the regional immune system in the intestinal tract[J].Front Immunol,2020,11:575.
[16] WANG C,LI Q,REN J.Microbiota-immune interaction in the pathogenesis of gut-derived infection[J].Front Immunol,2019,10:1873.
[17] GUO M,LIU H,YU Y,et al.Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure[J].Gut Microbes,2023,15(1):2190304.
[18] HAYS K E,PFAFFINGER J M,RYZNAR R.The interplay between gut microbiota,short-chain fatty acids,and implications for host health and disease[J].Gut Microbes,2024,16(1):2393270.
[19] CHEN Y,CUI W,LI X,et al.Interaction between commensal bacteria,immune response and the intestinal barrier in inflammatory bowel disease[J].Front Immunol,2021,12:761981.
[20] RINNINELLA E,RAOUL P,CINTONI M,et al.What is the healthy gut microbiota composition?A changing ecosystem across age,environment,diet,and diseases[J].Microorga-nisms,2019,7(1):14.
[21] SONG M,CHAN A T,SUN J.Influence of the gut microbiome,diet,and environment on risk of colorectal cancer[J].Gastroenterology,2020,158(2):322-340.
[22] LIU Z,LI N,DANG Q,et al.Exploring the roles of intestinal flora in enhanced recovery after surgery[J].iScience,2023,26(2):105959.
[23] KIHL P,KRYCH L,DENG L,et al.Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination[J].PLoS One,2022,17(4):e0266719.
[24] YUAN X,CHANG C,CHEN X,et al.Emerging trends and focus of human gastrointestinal microbiome research from 2010-2021:a visualized study[J].J Transl Med,2021,19(1):327.
[25] IBRAHIM I,SYAMALA S,AYARIGA J A,et al.Modulatory effect of gut microbiota on the gut-brain,gut-bone axes,and the impact of cannabinoids[J].Metabolites,2022,12(12):1247.
[26] ZHOU D,PAN Q,XIN F Z,et al.Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier[J].World J Gastroenterol,2017,23(1):60-75.
[27] LI C,PI G,LI F.The role of intestinal flora in the regulation of bone homeostasis[J].Front Cell Infect Microbiol,2021,11:579323.
[28] YUAN S,SHEN J.Bacteroides vulgatus diminishes colonic microbiota dysbiosis ameliorating lumbar bone loss in ovariectomized mice[J].Bone,2021,142:115710.
[29] LYU Z,HU Y,GUO Y,et al.Modulation of bone remodeling by the gut microbiota:a new therapy for osteoporosis[J].Bone Res,2023,11(1):31.
[30] LEE C S,KIM J Y,KIM B K,et al.Lactobacillus-fermented milk products attenuate bone loss in an experimental rat model of ovariectomy-induced post-menopausal primary osteoporosis[J].J Appl Microbiol,2021,130(6):2041-2062.
[31] YAN J, HERZOG J W, TSANG K,et al.Gut microbiota induce IGF-1 and promote bone formation and growth[J].Proc Natl Acad Sci U S A,2016,113(47):E7554-E7563.
[32] LU L,LI J,LIU L,et al.Grape seed extract prevents oestrogen deficiency-induced bone loss by modulating the gut microbiota and metabolites[J].Microb Biotechnol,2024,17(6):e14485.
[33] ZEIBICH L,KOEBELE S V,BERNAUD V E,et al.Surgical menopause and estrogen therapy modulate the gut microbiota,obesity markers,and spatial memory in rats[J].Front Cell Infect Microbiol,2021,11:702628.
[34] LI J Y,YU M,PAL S,et.al.Parathyroid hormone-dependent bone formation requires butyrate production by intestinal microbiota[J].J Clin Invest,2020,130(4):1767-1781.
[35] YU M,MALIK TYAGI A,LI J Y,et al.PTH induces bone loss via microbial-dependent expansion of intestinal TNF+ T cells and Th17 cells[J].Nat Commun,2020,11(1):468.
[36] BILEZIKIAN J P,FORMENTI A M,ADLER R A,et al.Vitamin D:dosing,levels,form,and route of administration:does one approach fit all?[J].Rev Endocr Metab Disord,2021,22(4):1201-1218.
[37] SUN J,ZHANG Y G.Vitamin D receptor influences intestinal barriers in health and disease[J].Cells,2022,11(7):1129.
[38] QIN C,XIE Y,WANG Y,et al.Impact of lactobacillus casei BL23 on the host transcriptome,growth and disease resis-tance in larval zebrafish[J].Front Physiol,2018,9:1245.
[39] GIUSTINA A,DI FILIPPO L,ALLORA A,et al.Vitamin D and malabsorptive gastrointestinal conditions:a bidirectional relationship?[J].Rev Endocr Metab Disord,2023,24(2):121-138.
[40] DE SIRE A,DE SIRE R,CURCI C,et al.Role of dietary supplements and probiotics in modulating microbiota and bone health:the gut-bone axis[J].Cells,2022,11(4):743.
相似文獻/References:
[1]劉磊,萬春友,全先輝,等.鎖定鋼板內固定結合肱骨頭植骨重建治療
肱骨近端Neer三、四部分骨折[J].中醫(yī)正骨,2015,27(10):52.
[2]徐偉鋒,葉健,吳連國.強骨飲對骨質疏松性股骨頸骨折患者全髖關節(jié)置換術后
血清骨代謝生化指標和骨密度的影響[J].中醫(yī)正骨,2015,27(02):12.
XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(強骨飲,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):12.
[3]龔江浩.股骨近端防旋髓內釘聯(lián)合抗骨質疏松藥物治療
不穩(wěn)定型老年股骨轉子間骨折的臨床觀察[J].中醫(yī)正骨,2015,27(04):29.
GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):29.
[4]李冠慧,李燦東,李西海,等.雌激素調控絕經后骨質疏松癥骨吸收-骨形成
耦聯(lián)失衡的機制[J].中醫(yī)正骨,2016,28(02):36.
[5]費國芳,費紅良,王金法.兩種內固定方法治療老年不穩(wěn)定性股骨轉子間骨折的對比研究[J].中醫(yī)正骨,2016,28(05):9.
FEI Guofang,FEI Hongliang,WANG Jinfa.Comparison of two kinds of internal fixation for treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):9.
[6]陳思凱,邢金明.骨水泥強化椎弓根螺釘內固定治療老年胸腰椎壓縮性骨折[J].中醫(yī)正骨,2016,28(05):35.
[7]孫鵬,譚磊,閻乾,等.人工肱骨頭置換術治療老年肱骨近端Neer三、四部分骨折[J].中醫(yī)正骨,2016,28(05):43.
[8]王博,吳鵬,史曉林.強骨飲對去卵巢骨質疏松大鼠骨顯微結構的影響[J].中醫(yī)正骨,2016,28(07):6.
WANG Bo,WU Peng,SHI Xiaolin.A retrospective trial of postural reduction combined with percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):6.
[9]馮建軍,鄒浩,朱海燕,等.槲皮素對去卵巢大鼠血清骨鈣素和股骨Ⅰ型膠原蛋白水平的影響[J].中醫(yī)正骨,2016,28(07):10.
FENG Jianjun,ZOU Hao,ZHU Haiyan,et al.Leverage bone grafting and pedicle screw internal fixation through posterior approach for treatment of thoracolumbar fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):10.
[10]王吉利,萬雷,張志海,等.抑制Dickkopf-1和Sclerostin表達對人成骨肉瘤細胞MG63骨代謝調節(jié)相關蛋白表達水平的影響[J].中醫(yī)正骨,2016,28(09):13.
WANG Jili,WAN Lei,ZHANG Zhihai,et al.Effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(12):13.